In This Article:
Amidst a backdrop of global economic uncertainty and fluctuating market indices, Sweden's tech sector continues to show resilience and potential for high growth. In this article, we will explore three Swedish tech stocks that stand out due to their innovative capabilities and strong market positioning in the current economic climate.
Top 10 High Growth Tech Companies In Sweden
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Truecaller | 20.32% | 21.61% | ★★★★★★ |
| Fortnox | 20.18% | 22.60% | ★★★★★★ |
| Xbrane Biopharma | 53.90% | 118.02% | ★★★★★★ |
| Bonesupport Holding | 33.76% | 31.20% | ★★★★★★ |
| Scandion Oncology | 40.71% | 75.34% | ★★★★★★ |
| Hemnet Group | 20.13% | 25.41% | ★★★★★★ |
| Skolon | 31.76% | 121.72% | ★★★★★★ |
| BioArctic | 42.38% | 98.40% | ★★★★★★ |
| Yubico | 20.43% | 42.51% | ★★★★★★ |
| KebNi | 34.75% | 86.11% | ★★★★★★ |
We'll examine a selection from our screener results.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden and has a market cap of SEK16.08 billion.
Operations: BioArctic AB focuses on developing biological drugs targeting central nervous system disorders. Its primary revenue stream is derived from biotechnology, generating SEK299.35 million.
BioArctic's revenue is projected to grow at 42.4% annually, significantly outpacing the Swedish market's 1% growth rate. Despite a net loss of SEK 68.43 million in Q2 2024, this marks an improvement from the previous year's SEK 102.31 million loss. The company's earnings are forecasted to increase by an impressive 98.4% per year, driven by advancements such as exidavnemab and collaborations with Eisai on Alzheimer's treatments like Leqembi®. With R&D expenses reflecting a strong commitment to innovation, BioArctic is positioned for substantial future growth in biotech and pharmaceuticals.
Embracer Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Embracer Group AB (publ), along with its subsidiaries, develops and publishes PC, console, mobile, VR, and board games for the global market and has a market cap of SEK33.13 billion.
Operations: The company generates revenue primarily from PC/console games (SEK13.10 billion), tabletop games (SEK14.65 billion), mobile games (SEK5.87 billion), and entertainment & services (SEK6.13 billion).
Embracer Group, a major player in the gaming industry, has faced recent financial challenges with a net loss of SEK 2.18 billion in Q1 2024 compared to a net income of SEK 2.25 billion the previous year. Despite this, their forecasted earnings growth stands at an impressive 106.1% per year, indicating strong future potential. The company also invests heavily in R&D, allocating significant resources to innovation and development within its diverse portfolio of gaming studios and intellectual properties.